Strategic intelligence in Latin America

Trial and error

COVID-19 vaccine trials politicized in Brazil.

This content is for Individual and Institutional members only.
Login Join Now
 

Free Trial

The first 14 days are free (credit card details required). Cancel at anytime.

Request Topics

Personalise your experience by requesting topics for us to cover.

Full Access

Read every article, not just the most recent ones.


 

 

Important Notice
While the information in this article has been prepared in good faith, no representation, warranty, assurance or undertaking (express or implied) is or will be made, and no responsibility or liability is or will be accepted by Deheza Limited or by its officers, employees or agents in relation to the adequacy, accuracy, completeness or reasonableness of this article, or of any other information (whether written or oral), notice or document supplied or otherwise made available in connection with this article. All and any such responsibility and liability is expressly disclaimed.
This article has been delivered to interested parties for information only. Deheza Limited gives no undertaking to provide the recipient with access to any additional information or to update this article or any additional information, or to correct any inaccuracies in it which may become apparent.

This Week

Volume 1 – Issue 10

Editor’s Note

Welcome to the tenth Issue of Tidings. Politics in Latin America is never dull, this week it is Peru’s turn to light up the Andean cone.

Musical chairs

Vizcarra ousted, Merino resigned, Silva-Santisteban rejected, now Sagasti.

Fine time

Central Bank sanctions Itaú in Paraguay.

Coal’s over

Chile signals intention to accelerate closure of coal generators.

Train reaction

Chinese interest returns to Mexican infrastructure projects.

Watching the Hass grow

Avocado production continues to grow in Colombia.

Lags to riches

Poor connectivity holds back El Salvador.

Doubling down

The City of Buenos Aires begins licensing online gambling.

Trial and error

COVID-19 vaccine trials politicized in Brazil.

Stranger danger

Brands risk their reputations with unknown influencers.